That facility is located in Holly Springs, N.C., and is owned by Novartis of Basel, Switzerland. It can now manufacture cell-based vaccine against seasonal as well as pandemic influenza viruses.
With the approval of manufacturing in the Holly Springs facility, the capacity for seasonal influenza vaccine production in the United States can increase by at least 50 million doses.
More Articles on Quality:
Despite Guidelines, Antibiotics Prescribed at High Rate for Bronchitis
New Pathogen-Identification Method Leads to Cost Savings: Study
Kaiser South Sacramento Patients Potentially Exposed to Whooping Cough
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
